G Lahat

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. doi request reprint New perspectives for staging and prognosis in soft tissue sarcoma
    G Lahat
    Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe St, Unit 1104, Houston, TX, 77030, USA
    Ann Surg Oncol 15:2739-48. 2008
  2. doi request reprint Pancreatic incidentalomas: high rate of potentially malignant tumors
    Guy Lahat
    Department of Surgery, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    J Am Coll Surg 209:313-9. 2009
  3. doi request reprint Molecular prognosticators of complex karyotype soft tissue sarcoma outcome: a tissue microarray-based study
    G Lahat
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Oncol 21:1112-20. 2010
  4. doi request reprint Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent
    D A Anaya
    Department of Surgery, Baylor College of Medicine, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX, USA
    Ann Oncol 21:397-402. 2010
  5. doi request reprint Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients
    G Lahat
    Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 16:2579-86. 2009
  6. doi request reprint Outcome of locally recurrent and metastatic angiosarcoma
    G Lahat
    Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 16:2502-9. 2009
  7. doi request reprint Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches
    G Lahat
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0444, Houston, Texas, USA
    Ann Surg Oncol 15:1585-93. 2008
  8. doi request reprint Efficacy of high vs low dose TNF-isolated limb perfusion for locally advanced soft tissue sarcoma
    I Nachmany
    Department of Surgery B, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Eur J Surg Oncol 35:209-14. 2009
  9. pmc Vimentin is a novel AKT1 target mediating motility and invasion
    Q S Zhu
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Oncogene 30:457-70. 2011

Collaborators

Detail Information

Publications9

  1. doi request reprint New perspectives for staging and prognosis in soft tissue sarcoma
    G Lahat
    Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe St, Unit 1104, Houston, TX, 77030, USA
    Ann Surg Oncol 15:2739-48. 2008
    ..Data suggest that the current American Joint Committee on Cancer (AJCC) soft tissue sarcoma (STS) staging criteria merit further evaluation. We sought to identify and validate factors as enhanced descriptors of STS clinical behavior...
  2. doi request reprint Pancreatic incidentalomas: high rate of potentially malignant tumors
    Guy Lahat
    Department of Surgery, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    J Am Coll Surg 209:313-9. 2009
    ..Pancreatic incidentaloma (PI) is an increasingly common diagnosis that has received little attention. We characterized these tumors and compared them with symptomatic pancreatic tumors (nonincidentaloma [NI])...
  3. doi request reprint Molecular prognosticators of complex karyotype soft tissue sarcoma outcome: a tissue microarray-based study
    G Lahat
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Oncol 21:1112-20. 2010
    ..Molecular markers are currently being utilized as sensitive prognosticators of cancer patient outcome. We sought to identify prognostic biomarkers for complex karyotype soft tissue sarcoma (STS)...
  4. doi request reprint Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent
    D A Anaya
    Department of Surgery, Baylor College of Medicine, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX, USA
    Ann Oncol 21:397-402. 2010
    ..Our objective was to develop a RPS disease-specific nomogram capable of stratifying patients based on probability of overall survival (OS) after resection...
  5. doi request reprint Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients
    G Lahat
    Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 16:2579-86. 2009
    ..Consequently, we evaluated the outcome of elderly patients amenable to complete surgical resection treated at a single institution...
  6. doi request reprint Outcome of locally recurrent and metastatic angiosarcoma
    G Lahat
    Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 16:2502-9. 2009
    ..Angiosarcoma (AS) is a rare soft tissue sarcoma with an enhanced propensity for local and systemic failure. The outcome of locally recurrent and metastatic AS treated at a single institution was evaluated...
  7. doi request reprint Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches
    G Lahat
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0444, Houston, Texas, USA
    Ann Surg Oncol 15:1585-93. 2008
    ..We hypothesized that WD and DD have distinct biological behaviors mandating different treatments...
  8. doi request reprint Efficacy of high vs low dose TNF-isolated limb perfusion for locally advanced soft tissue sarcoma
    I Nachmany
    Department of Surgery B, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Eur J Surg Oncol 35:209-14. 2009
    ..The purpose of this study was to compare two groups of patients with locally advanced limb STS, that was treated with high and low dose TNF-ILP, in terms of limb preservation...
  9. pmc Vimentin is a novel AKT1 target mediating motility and invasion
    Q S Zhu
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Oncogene 30:457-70. 2011
    ..Insights into this mesenchymal-related molecular mechanism may facilitate the development of critically lacking therapeutic options for these devastating malignancies...